Skip to main content
Premium Trial:

Request an Annual Quote

Wamberg Genomic Advisers: Robert Green

Wamberg Genomic Advisers has appointed Robert Green to its advisory board. A medical geneticist and physician-scientist, Green directs the G2P Research Program in the Division of Genetics at Brigham and Women's Hospital and Harvard Medical School. He is principal investigator of the MedSeq project, an NIH-funded randomized trial to explore the use of whole-genome sequencing in the clinical practice of medicine, and co-leads the BabySeq project, evaluating sequencing in newborns.

Green also directs the recently established Brigham Preventive Genomics Clinic, which offers comprehensive genome sequencing and interpretation to healthy adults and their children. He was the lead author of the published recommendations from the American College of Medical Genetics and Genomics for management of incidental findings in clinical sequencing. As an advisor to Wamberg, Green will help guide the firm in its further development of product offerings and programs as well as lead the selection of future advisory board members from the scientific community. 

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.